JF
LYEL icon

Jump Financial’s Lyell Immunopharma LYEL Stock Holding History

Jump Financial’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
21,956
+1,833
+9% +$33.2K ﹤0.01% 1665
2026
Q1 		$404K Buy
+20,123
New +$470K 0.01% 1348
2022
Q1 		– Sell
-2,065
Closed -$320K – 1745
2021
Q4 		$320K Buy
+2,065
New +$461K 0.02% 856

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Jump Financial's LYEL Position: Q2 2026 in Review

Jump Financial increased its Lyell Immunopharma (LYEL) stake by 9.1% in Q2 2026, buying an estimated $33.2K and bringing the position to 21,956 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Jump Financial first reported a position in LYEL in Q4 2021 and has held it in 3 quarters since. The position peaked at $404K in Q1 2026. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Jump Financial held 21,956 shares of Lyell Immunopharma worth $308K as of Q2 2026.
  • Jump Financial bought 1,833 Lyell Immunopharma shares in Q2 2026, an estimated $33.2K.
  • Lyell Immunopharma made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1665 holding.
  • Jump Financial first reported a position in Lyell Immunopharma in Q4 2021 and has held it in 3 quarters since.
  • Jump Financial's Lyell Immunopharma position peaked at $404K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.